Literature DB >> 15219383

Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.

Tomasz Bednarczuk1, Yuji Hiromatsu, Naoko Seki, Rafał Płoski, Tomoka Fukutani, Alina Kuryłowicz, Krystian Jazdzewski, Krzysztof Chojnowski, Kyogo Itoh, Janusz Nauman.   

Abstract

Tumor necrosis factor (TNF)-alpha plays a central role in the development of ophthalmopathy in patients with Graves' disease (GD). The aim of this study was to investigate the association of TNF promoter polymorphisms at positions -1031 (T-1031C), -863 (C-863A), -857 (C-857T), -308 (G-308A), and -238 (G-238A) with Graves' ophthalmopathy (GO). We studied the distribution of TNF and human leukocyte antigen (HLA) DRB1 alleles in 228 Polish white patients with GD, 106 of whom had ophthalmopathy (NOSPECS class > or = III) and 248 healthy subjects. TNF -308A and HLA-DRB1*03 alleles were significantly increased in patients with GD compared with healthy subjects. Stratification analysis revealed no independent association of -308A with GD when the DRB1*03 status was considered. Subdividing GD according to eye involvement revealed that the distribution of TNF promoter haplotypes differed significantly in patients with or without ophthalmopathy. The haplotype containing the -238A allele was absent in GO. The association of G-238A with GO was independent of DRB1 alleles. These results indicate that TNF G-308A is associated with susceptibility to GD (however, this association is not independent of HLA-DRB1*03) and that TNF G-238A is associated with the development of ophthalmopathy, suggesting that G-238A or a gene in linkage disequilibrium may be disease modifying in GD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219383     DOI: 10.1016/j.humimm.2004.02.033

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ.

Authors:  Mehdi Anvari; Omid Khalilzadeh; Alireza Esteghamati; Fatemeh Momen-Heravi; Mahdi Mahmoudi; Shadi Abdar Esfahani; Armin Rashidi; Aliakbar Amirzargar
Journal:  Endocrine       Date:  2010-03-05       Impact factor: 3.633

2.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Authors:  Krystian Jazdzewski; Tomasz Bednarczuk; Magdalena Stepnowska; Sandya Liyanarachchi; Krystyna Suchecka-Rachon; Janusz Limon; Krzysztof Narkiewicz
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

3.  Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study.

Authors:  Alina Kurylowicz; Piotr Miśkiewicz; Ewa Bar-Andziak; Janusz Nauman; Tomasz Bednarczuk
Journal:  Thyroid Res       Date:  2009-11-03

4.  Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.

Authors:  Yu-Huei Liu; Ching-Chu Chen; Li-Ling Liao; Lei Wan; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2012-11-19       Impact factor: 8.410

5.  Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.

Authors:  Beata Jurecka-Lubieniecka; Rafal Ploski; Dorota Kula; Aleksandra Krol; Tomasz Bednarczuk; Zofia Kolosza; Andrzej Tukiendorf; Sylwia Szpak-Ulczok; Anita Stanjek-Cichoracka; Joanna Polanska; Barbara Jarzab
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

6.  Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.

Authors:  Rafał Płoski; Oliver J Brand; Beata Jurecka-Lubieniecka; Maria Franaszczyk; Dorota Kula; Paweł Krajewski; Muhammad A Karamat; Matthew J Simmonds; Jayne A Franklyn; Stephen C L Gough; Barbara Jarząb; Tomasz Bednarczuk
Journal:  PLoS One       Date:  2010-11-25       Impact factor: 3.240

7.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

8.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

9.  Investigation of -308G>A and -1031T>C polymorphisms in the TNFA promoter region in Polish peptic ulcer patients.

Authors:  Aleksandra Sałagacka; Marta Żebrowska; Agnieszka Jeleń; Marek Mirowski; Ewa Balcerczak
Journal:  Gut Liver       Date:  2014-11-15       Impact factor: 4.519

10.  Association between polymorphisms in the TSHR gene and Graves' orbitopathy.

Authors:  Beata Jurecka-Lubieniecka; Rafal Ploski; Dorota Kula; Konrad Szymanski; Tomasz Bednarczuk; Urszula Ambroziak; Kornelia Hasse-Lazar; Lidia Hyla-Klekot; Andrzej Tukiendorf; Zofia Kolosza; Barbara Jarzab
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.